Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome.

about

Generic atorvastatin is as effective as the brand-name drug (LIPITOR®) in lowering cholesterol levels: a cross-sectional retrospective cohort study.Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.

P2860

Q33912919-08AB034D-B826-4C76-9D68-26D11C374AA9 Q55005295-E6FE2786-2D75-4982-95BA-2CC993A3216C

P2860

Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome.

Item

http://www.wikidata.org/entity/Q36877268

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparative Effectiveness of G ...... th an Acute Coronary Syndrome.

@en

type

Item

label

Comparative Effectiveness of G ...... th an Acute Coronary Syndrome.

@en

prefLabel

Comparative Effectiveness of G ...... th an Acute Coronary Syndrome.

@en

P1476

Comparative Effectiveness of G ...... th an Acute Coronary Syndrome.

@en

P2093

Alice Chong

http://www.w3.org/2001/XMLSchema#string

Cynthia A Jackevicius

http://www.w3.org/2001/XMLSchema#string

Dennis T Ko

http://www.w3.org/2001/XMLSchema#string

Jack V Tu

http://www.w3.org/2001/XMLSchema#string

Maria Koh

http://www.w3.org/2001/XMLSchema#string

Peter C Austin

http://www.w3.org/2001/XMLSchema#string

P2860

LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor) in Thai hypercholesterolemic subjects -- a randomized crossover study, the first report from Thailand

Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm.

Are generic and brand-name statins clinically equivalent? Evidence from a real data-base.

Beliefs about generic drugs among elderly adults in hospital-based primary care practices

Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.

P304

e003350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/JAHA.116.003350

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Harlan M. Krumholz

Joseph S. Ross

Therese A. Stukel

P577

2016-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27098970

http://www.w3.org/2001/XMLSchema#string

P932

4859299

http://www.w3.org/2001/XMLSchema#string

Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome.

about

P2860

P2860

Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932